Seres Therapeutics, Inc.(NasdaqGS:MCRB) dropped from S&P Biotechnology Select Industry Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.78 USD | -1.85% | -31.25% | -44.02% |
Jun. 11 | Nestle's Health Unit to Take Full Control of Microbiota-Based Therapeutic | CI |
Jun. 07 | Canaccord Genuity Adjusts Price Target on Seres Therapeutics to $10 From $15, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.02% | 120M | |
+17.13% | 124B | |
+16.36% | 109B | |
-7.41% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-8.24% | 16.61B | |
-37.63% | 16.43B | |
+2.24% | 13.4B | |
+24.80% | 11.47B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Seres Therapeutics, Inc.(NasdaqGS: MCRB) dropped from S&P Biotechnology Select Industry Index